5-alpha Reductase inhibitors in prostate cancer: from clinical trials to clinical practice

Eur Urol. 2013 May;63(5):788-9; discussion 790-1. doi: 10.1016/j.eururo.2012.12.035. Epub 2013 Jan 2.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • 5-alpha Reductase Inhibitors / administration & dosage*
  • Antineoplastic Agents, Hormonal / administration & dosage*
  • Azasteroids / administration & dosage*
  • Dutasteride
  • Humans
  • Kallikreins / blood*
  • Male
  • Prostate-Specific Antigen / blood*
  • Prostatectomy*
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / surgery*

Substances

  • 5-alpha Reductase Inhibitors
  • Antineoplastic Agents, Hormonal
  • Azasteroids
  • KLK3 protein, human
  • Kallikreins
  • Prostate-Specific Antigen
  • Dutasteride